Visiativ SA

EPA:ALVIV.PA

37 (EUR) • At close August 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q32012 Q22012 Q12011 Q4
Revenue 154.9122.6148.4110.4122.791.7107.39682.549118.17986.775101.18765.51870.69456.48661.09647.13756.40427.65728.94922.16428.48622.09912.29611.69111.69111.69111.691
Cost of Revenue 116.395.9155.684.3111.587.398.19381.823105.72883.40786.8165.78263.86453.76655.55146.35151.80427.91226.85822.68724.59122.1885.815.6985.6985.6985.698
Gross Profit 38.626.7-7.226.111.24.49.2030.72612.4513.36814.377-0.2646.832.725.5450.7864.6-0.2552.091-0.5233.895-0.0896.4865.9925.9925.9925.992
Gross Profit Ratio 0.2490.218-0.0490.2360.0910.0480.0860.0090.1050.0390.142-0.0040.0970.0480.0910.0170.082-0.0090.072-0.0240.137-0.0040.5270.5130.5130.5130.513
Reseach & Development Expenses 14.8013.6010.7000003.6663.6663.6173.3072.8322.5992.2152.742.3442.1841.6421.86900000
General & Administrative Expenses 000000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000000
SG&A 25.823.3-19.120.50.30.20.4850.3261.35600000000.68700.46300.4450.2640.2640.2640.2640.2640.264
Other Expenses -0.3-0.32-1.50.3-1.2-2.178-1.256-0.699000000000000000000
Operating Expenses 26.123.6-21.12222.41.42.6631.5822.0552.7673.8951.5841.6221.9950.7111.0051.8981.2442.1381.6551.3283.4250.2640.2640.2640.2640.264
Operating Income 12.53.113.94.111.236.54-0.85610.3961.58212.577-1.2546.8241.5266.1840.1723.901-1.5570.743-2.1922.57-0.924-0.2190.2880.2880.2880.288
Operating Income Ratio 0.0810.0250.0940.0370.0910.0330.061-0.010.0880.0180.124-0.0190.0970.0270.1010.0040.069-0.0560.026-0.0990.09-0.042-0.0180.0250.0250.0250.025
Total Other Income Expenses Net -2.71.5-1.8-0.9-6.6-0.8-1.093-1.347-1.323-1.734-2.76-0.886-1.702-0.974-1.516-0.531-1.328-0.043-0.838-0.094-0.077-2.7150.060.0270.0270.0270.027
Income Before Tax 9.84.612.13.24.62.25.447-2.2039.073-0.1529.817-2.145.1220.5524.668-0.3592.573-1.6-0.095-2.2862.493-3.639-0.1590.3150.3150.3150.315
Income Before Tax Ratio 0.0630.0380.0820.0290.0370.0240.051-0.0270.077-0.0020.097-0.0330.0720.010.076-0.0080.046-0.058-0.003-0.1030.088-0.165-0.0130.0270.0270.0270.027
Income Tax Expense 2.50.61.71.3-4.50.50.2050.8661.7071.491.6810.8270.7990.0570.4760.0740.4140.1460.1510.0310.2541.408-0.2890.0260.0260.0260.026
Net Income 6.63.49.81.28.61.15.807-4.3436.085-3.4686.928-3.6414.2190.5864.827-0.4342.155-1.746-0.247-2.3162.251-2.2160.1290.2890.2890.2890.289
Net Income Ratio 0.0430.0280.0660.0110.070.0120.054-0.0530.051-0.040.068-0.0560.060.010.079-0.0090.038-0.063-0.009-0.1050.079-0.10.0110.0250.0250.0250.025
EPS 1.450.752.20.271.970.251.49-1.111.56-0.891.81-0.920.930.171.37-0.120.72-0.59-0.082-0.790.96-0.990.110.240.240.240.24
EPS Diluted 1.430.742.160.271.950.251.49-1.111.56-0.891.81-0.920.930.171.37-0.120.72-0.59-0.082-0.790.96-0.990.110.240.240.240.24
EBITDA 16.97.818.48.716.66.510.2652.30615.0854.00214.9110.6078.1172.7587.1980.765.089-0.3912.031-0.7653.792-0.2230.1240.4680.4680.4680.468
EBITDA Ratio 0.1090.0640.1240.0790.1350.0710.0960.0280.1280.0460.1470.0090.1150.0490.1180.0160.09-0.0140.07-0.0350.133-0.010.010.040.040.040.04